Given that both EBV+DLBCL and HBV+DLBCL are associated with viral infections, we suspect that the PD1/PD-L1 cell signaling pathway may play an important role in the clinical prognosis of DLBCL patients with concurrent HBV infection. The gene discussed is PDCD1; the disease is diffuse large B-cell lymphoma.